Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Article in English | IMSEAR | ID: sea-92906

ABSTRACT

The treatment of stroke is multifaceted, and is governed by three, well established goals: 1) To minimize the extent of brain; 2) To medically support the stroke patient; and 3) To prevent further brain injury secondary to initial event or repeated vascular insults. Certain guidelines for emergency care, based on clinical experience and knowledge of pathophysiology, have been accepted in many institutions as the standard. This article provides guidelines about the current management of acute ischemic stroke based on currently available data from clinical trials. The target audiences for this article are emergency room physicians and neurologists, who manage the patients during the first few hours after stroke.


Subject(s)
Adult , Ancrod/therapeutic use , Anticoagulants/therapeutic use , Brain Ischemia/drug therapy , Clinical Trials as Topic , Fibrinolytic Agents/therapeutic use , Humans , International Normalized Ratio , Intracranial Pressure/drug effects , Neuroprotective Agents/therapeutic use
2.
Arq. neuropsiquiatr ; 53(1): 157-68, mar. 1995.
Article in Portuguese | LILACS | ID: lil-155495

ABSTRACT

É apresentada avaliaçäo crítica da importância da hemorreologia no estabelecimento da conduta terapêutica clínica na insuficiência cerebrovascular aguda. Com essa finalidade säo revistos aspectos relativos a fluxo sanguíneo cerebral, insuficiência cerebrovascular e hemorreologia clínica. Em funcçäo desses aspectos säo avaliados alguns dos principais medicamentos utilizados no presente no tratamento do acidente vascular cerebral e säo discutidas normas gerais para prevençäo e tratamento das isquemias cerebrais


Subject(s)
Humans , Animals , Male , Female , Brain Ischemia/physiopathology , Cerebrovascular Circulation/physiology , Hemorheology , Ancrod/therapeutic use , Brain Ischemia/blood , Brain Ischemia/drug therapy , Brain Ischemia/prevention & control , Cerebral Infarction/physiopathology , Fibrinolytic Agents/therapeutic use , Hemodilution , Pentoxifylline/therapeutic use , Time Factors , Vascular Resistance/physiology , Blood Viscosity/physiology , Xanthines/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL